17-β-羟基类固醇脱氢酶13是一种与nafld组织学特征相关的肝视黄醇脱氢酶
研究探讨rs6834314及其邻近基因HSD17B13与NAFLD组织学特征的关联及功能。在768例经活检证实的成人白人NAFLD中,rs6834314次要等位基因与脂肪变性增加但炎症、气球样变、Mallory-Denk小体和肝酶水平降低相关。HSD17B13在NAFLD中表达升高5.9倍(P=0.003),定位于脂滴,具有视黄醇脱氢酶活性,特定变异导致酶活性丧失。
要点
- rs6834314次要等位基因与脂肪变性增加但炎症、气球样变和肝酶降低相关。
- rs72613567与rs6834314高度连锁(r2=0.94),产生外显子6跳跃和G插入剪接变异。
- HSD17B13在NAFLD肝内表达升高5.9倍(P=0.003),为脂滴相关视黄醇脱氢酶。
核心结论
- HSD17B13变异与NAFLD特定组织学特征相关,该酶为脂滴相关视黄醇脱氢酶,数据提示其通过酶活性在NAFLD中发挥作用。
研究设计与样本
- 研究纳入768例经活检证实的成人白人NAFLD患者,分析rs6834314及其邻近基因HSD17B13与组织学特征的关联,并开展功能研究。
主要发现
- rs6834314次要等位基因与脂肪变性增加但炎症、气球样变、Mallory-Denk小体和肝酶水平降低显著相关。
- rs72613567与rs6834314高度连锁(r2=0.94),其次要等位基因同时表达外显子6跳跃和G核苷酸插入变异,与NAFLD组织学关联模式相似。
- rs62305723(编码P260S突变)与气球样变和炎症降低显著相关。
- NAFLD患者肝内HSD17B13表达升高5.9倍(P=0.003)。
- HSD17B13靶向脂滴需保守氨基酸22-28序列和氨基酸71-106区域,其视黄醇脱氢酶活性依赖脂滴靶向和辅因子结合位点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. A single-nucleotide polymorphism (SNP), rs6834314, was associated with serum liver enzymes in the general population, presumably reflecting liver fat or injury. We studied rs6834314 and its nearest gene, 17-beta hydroxysteroid dehydrogenase 13 (HSD17B13), to identify associations with histological features of NAFLD and to characterize the functional role of HSD17B13 in NAFLD pathogenesis. The minor allele of rs6834314 was significantly associated with increased steatosis but decreased inflammation, ballooning, Mallory-Denk bodies, and liver enzyme levels in 768 adult Caucasians with biopsy-proven NAFLD and with cirrhosis in the general population. We found two plausible causative variants in the HSD17B13 gene. rs72613567, a splice-site SNP in high linkage with rs6834314 (r2 = 0.94) generates splice variants and shows a similar pattern of association with NAFLD histology. Its minor allele generates simultaneous expression of exon 6-skipping and G-nucleotide insertion variants. Another SNP, rs62305723 (encoding a P260S mutation), is significantly associated with decreased ballooning and inflammation. Hepatic expression of HSD17B13 is 5.9-fold higher (P = 0.003) in patients with NAFLD. HSD17B13 is targeted to lipid droplets, requiring the conserved amino acid 22-28 sequence and amino acid 71-106 region. The protein has retinol dehydrogenase (RDH) activity, with enzymatic activity dependent on lipid droplet targeting and cofactor binding site. The exon 6 deletion, G insertion, and naturally occurring P260S mutation all confer loss of enzymatic activity. Conclusion: We demonstrate the association of variants in HSD17B13 with specific features of NAFLD histology and identify the enzyme as a lipid droplet-associated RDH; our data suggest that HSD17B13 plays a role in NAFLD through its enzymatic activity.
引用
- Ma Y, Belyaeva OV, Brown PM, et al. 17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease. Hepatology. 2019. PMID: 30415504. doi:10.1002/hep.30350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。